IDT Australia (ASX:IDT) Buyback Yield %: -1.17 (As of Jul. 03, 2026)


What is IDT Australia Buyback Yield %?

IDT Australia ASX:IDT Buyback Yield % is -1.17 as of Jul. 03, 2026. The stock has 6 warning signs investors should review. Among 292 Drug Manufacturers companies, IDT Australia ranks worse than 54.45% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

IDT Australia's current buyback yield was -1.17%.

IDT Australia Buyback Yield % Historical Data

* Premium members only.

The historical data trend for IDT Australia's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IDT Australia Buyback Yield % Chart

IDT Australia Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Buyback Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.26 -1.14 -19.11 -7.86 -17.40

IDT Australia Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -7.73 -7.86 -13.83 -17.40 -0.76

ASX:IDT vs ZTS, UTHR: Buyback Yield % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, IDT Australia's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

IDT Australia Buyback Yield % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, IDT Australia's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where IDT Australia's Buyback Yield % falls into.


IDT Australia Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

IDT Australia's Buyback Yield for the fiscal year that ended in Jun. 2025 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 6.653) / 38.241342
=-17.40%

IDT Australia's annualized Buyback Yield for the quarter that ended in Dec. 2025 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (0 + 0.165) / 21.798726
=-0.76%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of -1.17 mean?
IDT Australia (ASX:IDT) has a Buyback Yield % of -1.17 as of Jul. 03, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on IDT Australia and its competitors. According to the industry distribution chart, IDT Australia ranks #159 out of 292 companies in the Drug Manufacturers industry, placing it in the top 54.5%.
Is IDT Australia's Buyback Yield % too high?
IDT Australia's current Buyback Yield % is -1.17. Based on the distribution chart, IDT Australia ranks #159 out of 292 companies in the Drug Manufacturers industry, which is below the industry midpoint.
How does IDT Australia's Buyback Yield % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, IDT Australia ranks #159 out of 292 companies for Buyback Yield %. This places IDT Australia in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Drug Manufacturers company?
A good Buyback Yield % depends on the Drug Manufacturers industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on IDT Australia and its competitors. IDT Australia's current Buyback Yield % is -1.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IDT Australia stock overvalued right now?
Based on GuruFocus' analysis, IDT Australia (ASX:IDT) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.17, compared to a current price of A$0.03 — trading 81.8% below its estimated fair value. The current Buyback Yield % is -1.17. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For IDT Australia (ASX:IDT), the current Buyback Yield % is -1.17 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

IDT Australia Business Description

Address 45 Wadhurst Drive, Boronia, Melbourne, VIC, AUS, 3155
IDT Australia Ltd produces, develops, and supplies pharmaceutical products. It is engaged in the provision of research and development and other technical services for the pharmaceutical and allied industries. The company is involved in the manufacture of Active Pharmaceutical Ingredients (API) and Finished Dose Forms (FDF), microbiological and analytical testing, clinical packaging, and pharmacy services. The company operates in Australia, Asia, Europe, and the USA.